MIR34C: A Non-Coding RNA Molecule with Potential as A Drug Target Or Biomarker
MIR34C: A Non-Coding RNA Molecule with Potential as A Drug Target Or Biomarker
MIR34C (hsa-miR-34c-5p) is a non-coding RNA molecule that has been identified as a potential drug target or biomarker. MIR34C is a member of the miRNA-34 cluster, which is a family of non-coding RNAs that play important roles in various cellular processes.
MIR34C is expressed in a variety of tissues and cells, including the brain, heart, liver, and muscle. It has been shown to be involved in several cellular processes, including cell growth, apoptosis, and inflammation.
One of the most promising aspects of MIR34C is its potential as a drug target. MIR34C has been shown to be involved in the regulation of several cellular processes, including cell survival and proliferation. Additionally, MIR34C has been shown to play a role in the regulation of cellular signaling pathways, including the TGF-β pathway.
MIR34C has also been shown to be involved in the regulation of inflammation. It has been shown to be involved in the regulation of the production of pro-inflammatory cytokines, such as TNF-伪 and IL-1尾. Additionally, MIR34C has been shown to play a role in the regulation of the apoptosis-related pathway, which is involved in the regulation of cell death.
In addition to its potential as a drug target, MIR34C also has potential as a biomarker. Its expression has been shown to be associated with several diseases, including cancer, neurodegenerative diseases, and autoimmune diseases. Additionally, MIR34C has been shown to be involved in the regulation of several biological processes that are important for human health, including cell growth, apoptosis, and inflammation.
Overall, MIR34C is a promising molecule for the development of new drugs or biomarkers. Further research is needed to fully understand its role in cellular processes and its potential as a drug or biomarker.
Protein Name: MicroRNA 34c
The "MIR34C Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR34C comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
MIR3529 | MIR3591 | MIR3605 | MIR3606 | MIR3609 | MIR361 | MIR3610 | MIR3611 | MIR3612 | MIR3613 | MIR3614 | MIR3615 | MIR3616 | MIR3617 | MIR3618 | MIR3619 | MIR362 | MIR3620 | MIR3621 | MIR3622A | MIR3622B | MIR363 | MIR3646 | MIR3648-1 | MIR3649 | MIR3650 | MIR3651 | MIR3652 | MIR3654 | MIR3655 | MIR3658 | MIR3659 | MIR365A | MIR365B | MIR3660 | MIR3661 | MIR3662 | MIR3663 | MIR3664 | MIR3665 | MIR3667 | MIR3667HG | MIR3668 | MIR367 | MIR3670-1 | MIR3670-2 | MIR3671 | MIR3672 | MIR3674 | MIR3675 | MIR3677 | MIR3678 | MIR3679 | MIR3680-1 | MIR3680-2 | MIR3681 | MIR3681HG | MIR3682 | MIR3683 | MIR3685 | MIR3686 | MIR3687 | MIR3688-1 | MIR3688-2 | MIR3689A | MIR3689B | MIR3689C | MIR3689D1 | MIR3689D2 | MIR3689F | MIR369 | MIR3690 | MIR3691 | MIR3692 | MIR370 | MIR3713 | MIR3714 | MIR371A | MIR371B | MIR372 | MIR373 | MIR374A | MIR374B | MIR374C | MIR375 | MIR376A1 | MIR376A2 | MIR376B | MIR376C | MIR377 | MIR378A | MIR378B | MIR378C | MIR378D1 | MIR378D2 | MIR378E | MIR378F | MIR378G | MIR378H | MIR378I
